BHOC — Business & Market Concept
Precision Oxygen Therapeutics
🔙 Back to Veterinary
💼 Business Overview
The Veterinary HBOC market represents a unique opportunity in the field of transfusion medicine and emergency veterinary care.
Market Opportunity
| Metric | Value |
|---|---|
| Global Veterinary Market | $XX billion (2024) |
| Transfusion Medicine Segment | $X billion |
| Growth Rate | X% CAGR |
| Key Drivers | Blood shortages, emergency care, exotic animal medicine |
🎯 Precision Oxygen Therapeutics — New Concept
The central concept is Precision Oxygen Therapeutics:
Focusing on oxygen delivery at the tissue level rather than on blood hemoglobin concentration alone.
Four Fundamental Questions
| Question | Description |
|---|---|
| 📍 WHERE | Where is oxygen needed? |
| ⏰ WHEN | When is additional oxygen delivery required? |
| 📊 HOW MUCH | How much oxygen is required to support tissue demand? |
| 🎮 CONTROL | How can oxygen delivery be supported in a controlled and continuous manner? |
📊 Market Research
Key Segments
| Segment | Description |
|---|---|
| Emergency & Critical Care | Trauma, hemorrhage, surgery |
| Transfusion Medicine | Blood substitutes, oxygen carriers |
| Exotic & Wildlife Medicine | Zoo, wildlife rehabilitation |
| Organ Preservation | Machine perfusion, transplantation |
Competitive Landscape
| Product | Type | Status |
|---|---|---|
| Oxyglobin | HBOC (veterinary) | FDA Approved (1998) |
| HBOC-201 (Hemopure) | HBOC (human) | Clinical use (South Africa) |
| Other HBOCs | Various | Research stage |
🤝 Strategic Partnerships
This section is available to approved partners only.
For more information, please contact:
Archil Jaliashvili
BHOC — Biological Hemoglobin Oxygen Carrier
🔒 Access Restricted
This section is for partners only.
To request access, please contact us with your credentials and area of interest.
🔙 Back to Veterinary
Last updated: 2026.08